Literature DB >> 7936233

Association of hippocampal sclerosis with cortical dysgenesis in patients with epilepsy.

A A Raymond1, D R Fish, J M Stevens, M J Cook, S M Sisodiya, S D Shorvon.   

Abstract

The possible dual occurrence of hippocampal sclerosis (HS) and other structural lesions (especially cortical dysgenesis [CD]) is well established in patients with chronic partial epilepsy. We describe the frequency of additional CD in a series of 100 patients with evidence of HS, using volumetric MRI. Additional, often subtle, CD was present in 15 patients: subependymal heterotopia (six), forme fruste of tuberous sclerosis (two), focal macrogyria (two), focal cortical dysplasia (one), laminar heterotopia (one), bilateral schizencephaly (one), and simplified gyral patterns (two). In contrast, in 46 healthy volunteers, only one had possible CD (p < 0.05). Only 2 of 15 patients had a history of childhood febrile convulsions. HS is a heterogeneous condition; patients being evaluated for temporal lobe surgery should be carefully screened for additional CD using appropriate MR techniques.

Entities:  

Mesh:

Year:  1994        PMID: 7936233     DOI: 10.1212/wnl.44.10.1841

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Focal cortical dysplasias: MR imaging, histopathologic, and clinical correlations in surgically treated patients with epilepsy.

Authors:  Nadia Colombo; Laura Tassi; Carlo Galli; Alberto Citterio; Giorgio Lo Russo; Giuseppe Scialfa; Roberto Spreafico
Journal:  AJNR Am J Neuroradiol       Date:  2003-04       Impact factor: 3.825

Review 2.  Mesial temporal lobe epilepsy: How do we improve surgical outcome?

Authors:  Maria Thom; Gary W Mathern; J Helen Cross; Edward H Bertram
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

3.  Magnetic resonance imaging in epilepsy with a fast FLAIR sequence.

Authors:  U C Wieshmann; S L Free; A D Everitt; P A Bartlett; G J Barker; P S Tofts; J S Duncan; S D Shorvon; J M Stevens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

4.  Chronic epilepsy due to low grade temporal lobe tumors and due to hippocampal sclerosis: do they differ in post-surgical outcome?

Authors:  Prasad S S V Vannemreddy; Andres M Kanner; Michel C Smith; Marvin Rossi; David Wallace; Siddharth N K Vannemreddy; Richard W Byrne
Journal:  J Neurooncol       Date:  2013-08-17       Impact factor: 4.130

5.  Potentially misleading extratemporal lobe lesions in patients with temporal lobe epilepsy.

Authors:  T M Alsaadi; L M Bateman; K D Laxer; N M Barbaro; E J Austin; P A Garcia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

Review 6.  Role of conventional magnetic resonance imaging in the screening of epilepsy with structural abnormalities: a pictorial essay.

Authors:  Xu Zhao; Zhiqiang Zhou; Wenzhen Zhu; Hongbing Xiang
Journal:  Am J Nucl Med Mol Imaging       Date:  2017-07-15

7.  Outcome of epilepsy surgery in focal cortical dysplasia.

Authors:  T Kral; H Clusmann; I Blümcke; R Fimmers; B Ostertun; M Kurthen; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

8.  Hippocampal abnormalities in an MR imaging series of patients with tuberous sclerosis.

Authors:  H P P Gama; A J da Rocha; R M F Valério; C J da Silva; L A L Garcia
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-06       Impact factor: 3.825

9.  Multisection proton MR spectroscopy for mesial temporal lobe epilepsy.

Authors:  Arístides A Capizzano; Peter Vermathen; Kenneth D Laxer; Gerald B Matson; Andrew A Maudsley; Brian J Soher; Norbert W Schuff; Michael W Weiner
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

10.  Patterns of hippocampal abnormalities in malformations of cortical development.

Authors:  M A Montenegro; D Kinay; F Cendes; A Bernasconi; N Bernasconi; A C Coan; L M Li; M M Guerreiro; C A M Guerreiro; I Lopes-Cendes; E Andermann; F Dubeau; F Andermann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.